With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

Jasper Therapeutics, Inc. (NASDAQ:JSPR) reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with chronic spontaneous urticaria (CSU).

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

Years before Jim Porter got his current job — back when the president of the Pro Football Hall of Fame was still a 400-pound man who wore purple suits and Porter was selling newspapers, not appearing ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ellen Green, a postgraduate researcher with the University of Reading, analyzed “Quarry 1” from the Nescot site and found “it ...

Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...

Women who used the Continuous Precision Medicine mobile application had a lower likelihood of misusing prescription opioids ...

Vision Net, a leading provider of network and technology solutions for carriers, enterprise businesses, healthcare organizations, and educational institutions, announced a series of significant ...

The city of Chico announced that it has been awarded a $12,746,798 grant to fund an innovative fiber utility project aimed at ...

Viking Therapeutics (VKTX) announced the initiation of a Phase 2 clinical trial of the oral tablet formulation of VK2735, the company’s dual ...

Modulation effects are one of our pedalboard’s essentials. But where do they come from and what do they do? We explore the history of modulation, from amps and studio hardware to compact stompboxes ...